Indications
For the short-term treatment of postoperative pain.The decision to prescribe a selective COX-2 inhibitor should be based on an assessment of the individual patient's overall risks (see sections 4.3, 4.4).
Composition
- Active substance
- parecoxib
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Rayzon
- Active substance
- parecoxib
- ATC code
- M01AH04
- Therapeutic area
- Pain, Postoperative
- Marketing authorisation holder
- Pharmacia Europe EEIG
- Status
- Withdrawn
- EU authorisation